Protyon aims to empower the decision-making process in cancer patients by providing molecular visualization of the disease.

Protyon is a Groningen-based startup that focuses on developing predictive software that leverages computational molecular modeling and artificial intelligence (AI) to assist in patient-specific decision-making for lung cancer treatment. Protyon secured a pre-seed investment, which will be used to advance their technology and establish a SaaS model.